4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-012967
EVP, Chief Dev. Officer sold 2,887 shares at $14.83 ($42,818)
From the SEC's structured data for this filing
Trades in this filing
Frenkel Ran · EVP, Chief Dev. Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-18 | Sale : show line 1 in the form | −2,887 | $14.83 | $42,818 | 46,126 | D |
| Open-market sales · 2,887 sh · avg $14.83 · $42,818 | ||||||
Loading xslF345X03/doc4.xml…